secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kyverna Therapeutics, Inc. (KYTX)
CIK:        0001994702
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0000950170-25-080896
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kyverna Therapeutics shareholders elect two Class I directors and ratify BDO as auditor at 2025 Annual Meeting
--------------------------------------------------------------------------------

- 30,546,469 shares (70.67% of outstanding) represented at May 29, 2025 Annual Meeting.
- Beth Seidenberg, M.D. elected with 18,161,970 votes for, 2,508,848 withheld.
- Fred E. Cohen, M.D., D. Phil. elected with 18,513,181 votes for, 2,157,637 withheld.
- Ratification of BDO USA, P.C. as auditor for 2025 passed with 30,374,716 for, 142,212 against, 29,541 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/0000950170-25-080896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/kytx-20250529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-080896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer